NCT04629729 2026-03-19FT819 in Subjects With B-cell MalignanciesFate TherapeuticsPhase 1 Active not recruiting54 enrolled
NCT06153251 2026-03-18A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple MyelomaJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyPhase 1 Recruiting187 enrolled
NCT05170828 2026-02-24Cryopreserved MMUD BM With PTCy for Hematologic MalignanciesOssium Health, Inc.Phase 1 Withdrawn
NCT05589896 2026-02-24A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesOssium Health, Inc.Phase 1/2 Recruiting12 enrolled